Barriers and proposed solutions to at‐home colorectal cancer screening tests in medically underserved health centers across three US regions to inform a randomized trial

Author:

Brodney Suzanne1ORCID,Bhat Roopa S.1,Tuan Jessica J.2ORCID,Johnson Gina3ORCID,May Folasade P2456ORCID,Glenn Beth A.27,Schoolcraft Kimberly8,Warner Erica T.1910ORCID,Haas Jennifer S.110ORCID

Affiliation:

1. Division of General Internal Medicine, Massachusetts General Hospital Boston Massachusetts USA

2. UCLA Kaiser Permanent Center for Health Equity, UCLA Center for Cancer Prevention and Control Research Jonsson Comprehensive Cancer Center Los Angeles California USA

3. Community Health Prevention Programs Great Plains Tribal Leaders' Health Board Rapid City South Dakota USA

4. Department of Medicine, David Geffen School of Medicine, UCLA Ronald Reagan Medical Center University of California Los Angeles Los Angeles California USA

5. Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine University of California Los Angeles Los Angeles California USA

6. Greater Los Angeles Veterans Affairs Healthcare System Los Angeles California USA

7. Department of Health Policy and Management UCLA Fielding School of Public Health Los Angeles California USA

8. Fight Colorectal Cancer Springfield Missouri USA

9. Clinical and Translational Epidemiology Unit Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA

10. Mongan Institute, Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA

Abstract

AbstractIntroductionAt‐home colorectal cancer (CRC) screening is an effective way to reduce CRC mortality, but screening rates in medically underserved groups are low. To plan the implementation of a pragmatic randomized trial comparing two population‐based outreach approaches, we conducted qualitative research on current processes and barriers to at‐home CRC screening in 10 community health centers (CHCs) that serve medically underserved groups, four each in Massachusetts and California, and two tribal facilities in South Dakota.MethodsWe conducted 53 semi‐structured interviews with clinical and administrative staff at the participating CHCs. Participants were asked about CRC screening processes, categorized into eight domains: patient identification, outreach, risk assessment, fecal immunochemical test (FIT) workflows, FIT‐DNA (i.e., Cologuard) workflows, referral for a follow‐up colonoscopy, patient navigation, and educational materials. Transcripts were analyzed using a Rapid Qualitative Analysis approach. A matrix was used to organize and summarize the data into four sub‐themes: current process, barriers, facilitators, and solutions to adapt materials for the intervention.ResultsEach site's process for stool‐based CRC screening varied slightly. Interviewees identified the importance of offering educational materials in English and Spanish, using text messages to remind patients to return kits, adapting materials to address health literacy needs so patients can access instructions in writing, pictures, or video, creating mailed workflows integrated with a tracking system, and offering patient navigation to colonoscopy for patients with an abnormal result.ConclusionProposed solutions across the three regions will inform a multilevel intervention in a pragmatic trial to increase CRC screening uptake in CHCs.

Funder

Stand Up To Cancer

Publisher

Wiley

Reference31 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3